This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

James R. Lehrich, MD; Barry G. W. Arnason, MD

Arch Neurol. 1976;33(6):404-405.

Abstract
• Serum neutralizing (Nt) antibodies to herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2), and histocompatibility (HL-A) types, were determined in multiple sclerosis (MS) patients and in control subjects. Titers of Nt antibodies to HSV-1 and to HSV-2 were increased among subjects bearing HL-A3 or HL-A7 or both, whether they suffered from MS or not. The increases were statistically significant in the MS group. The MS and control groups did not differ significantly in levels of HSV-1 or HSV-2 Nt antibodies.

Author Affiliations
From the Department of Neurology, Harvard Medical School and Massachusetts General Hospital, Boston.

Footnotes
Accepted for publication Dec 18, 1975.

Reprint requests to Department of Neurology, Massachusetts General Hospital, Boston, MA 02114 (Dr Lehrich).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Herpesviruses and Parkinsonism: Herpes Simplex Virus Types 1 and 2, and Cytomegalovirus Antibodies in Serum and CSF
Marttila et al.
Arch Neurol 1981;38:19-21.
ABSTRACT  

Epstein-Barr Virus Antibodies in Multiple Sclerosis
Sumaya et al.
Arch Neurol 1980;37:94-96.
ABSTRACT  

Viral Antibodies in Serum and CSF of Parkinsonian Patients and Controls
Elizan et al.
Arch Neurol 1979;36:529-534.
ABSTRACT  

Herpes Simplex Virus Subunit Antibodies in Patients With Parkinson's Disease
Marttila et al.
Arch Neurol 1978;35:668-671.
ABSTRACT  

Multiple Sclerosis: Explorations of Cause
Hussey
JAMA 1976;235:2630-2630.
ABSTRACT